CLINICAL TRIALS PROFILE FOR LAPAQUISTAT
✉ Email this page to a colleague
Clinical Trials for Lapaquistat
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00143663 ↗ | Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol | Completed | Takeda | Phase 3 | The purpose of this study is to determine if patients with elevated cholesterol, but not taking any other lipid medication, could lower their cholesterol with administration of lapaquistat acetate, once daily (QD). |
NCT00143676 ↗ | Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia | Completed | Takeda | Phase 3 | The purpose of this study is to determine the efficacy of lapaquistat acetate, once daily (QD), on lowering cholesterol in subjects already taking atorvastatin. |
NCT00249899 ↗ | Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia | Terminated | Takeda | Phase 3 | The purpose of this study is to evaluate lapaquistat acetate, once daily (QD), taken alone or with additional statin therapy on cholesterol levels in treating patients with elevated cholesterol. |
NCT00249912 ↗ | Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia | Completed | Takeda | Phase 3 | The purpose of this study is to evaluate lapaquistat acetate, once daily (QD), taken alone or with rosuvastatin on cholesterol levels in treating patients with elevated cholesterol. |
NCT00251680 ↗ | Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy. | Completed | Takeda | Phase 3 | The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with established lipid-lowering therapy in subjects with type 2 diabetes mellitus. |
NCT00256178 ↗ | Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. | Completed | Takeda | Phase 3 | The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with simvastatin on cholesterol levels in subjects with primary dyslipidemia |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Lapaquistat
Condition Name
Clinical Trial Locations for Lapaquistat
Trials by Country
Clinical Trial Progress for Lapaquistat
Clinical Trial Phase
Clinical Trial Sponsors for Lapaquistat
Sponsor Name